IP Archives of Cytology and Histopathology Research

Print ISSN: 2581-5725

Online ISSN: 2456-9267

CODEN : IACHCL

IP Archives of Cytology and Histopathology Research (ACHR) open access, peer-reviewed quarterly journal publishing since 2016 and is published under the Khyati Education and Research Foundation (KERF), is registered as a non-profit society (under the society registration act, 1860), Government of India with the vision of various accredited vocational courses in healthcare, education, paramedical, yoga, publication, teaching and research activity, with the aim of faster and better more...


Article type

Original Article


Article page

255-262


Authors Details

Syeda Hajra Fatima*, Shashikala , Vijay Sreedhar, Uzma Viqar, Ahmed Minhajuddin


Article Metrics


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 93

PDF Downloaded: 38


A study of Her-2/Neu oncogene expression in benign and malignant endometrial lesions and its association with clinicopathologic variables


Original Article

Author Details : Syeda Hajra Fatima*, Shashikala , Vijay Sreedhar, Uzma Viqar, Ahmed Minhajuddin

Volume : 6, Issue : 4, Year : 2021

Article Page : 255-262

https://doi.org/10.18231/j.achr.2021.056



Suggest article by email


Abstract

Introduction: Endometrial carcinoma is commonly diagnosed gynaecological malignancy in women and the incidence of endometrial cancer and associated mortality rates have increased in recent years. Endometrial hyperplasia is recognized precursor lesion of endometrial cancer and its timely detection offers an opportunity to prevent the development of endometrial cancer. Her-2/neu oncogene amplification has been implicated in the development and progression of many tumours and its overexpression may be involved in tumorigenesis of endometrial carcinoma as well. The present study was aimed to evaluate Immunohistochemical (IHC) expression of Her-2/neu oncogene in Benign and Malignant Endometrial Lesions and its correlation with clinicopathological features in order to define its potential prognostic significance.
Material and Methods : A total of 62 cases including 20 cases of endometrial hyperplasia and 42 cases of Endometrial Carcinoma were enrolled in the study. Clinical and pathologic information was obtained and recorded. Her-2/neu expression was evaluated by immunohistochemistry (IHC) on paraffin embedded tissue sections with Her-2/neu antibody. Overexpression was defined as complete, membrane, moderate to strong intensity staining in greater than 10% of cells.
Results: Positive HER-2/neu expression is seen in 45% cases of Endometrial Hyperplasia and in 54.76% cases of endometrial carcinoma. The Her-2/neu overexpression was observed in patients with advanced stage (p<0> Conclusion: In the present study Abnormal high Her-2/neu expression was observed in Endometrial carcinoma, correlating with High FIGO stage, high grade, lymph node metastasis, myometrial invasion and cervical invasion, indicating Her-2/neu expression analysis could be an important prognostic factor of Endometrial carcinoma.
 

Keywords: Endometrial carcinoma, Endometrial Hyperplasia, HER­2/neu, prognostic factor


How to cite : Fatima S H, Shashikala, Sreedhar V, Viqar U, Minhajuddin A, A study of Her-2/Neu oncogene expression in benign and malignant endometrial lesions and its association with clinicopathologic variables. IP Arch Cytol Histopathol Res 2021;6(4):255-262

Copyright © 2021 by author(s) and IP Arch Cytol Histopathol Res. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (creativecommons.org)







Open Abstract (Increase article citation) Wiki in hindi